These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16627456)

  • 1. The RIONI study rationale and design: validation of the first stored electrograms transmitted via home monitoring in patients with implantable defibrillators.
    Perings C; Klein G; Toft E; Moro C; Klug D; Böcker D; Trappe HJ; Korte T;
    Europace; 2006 Apr; 8(4):288-92. PubMed ID: 16627456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IEGM-online based evaluation of implantable cardioverter defibrillator therapy appropriateness.
    Perings C; Korte T; Trappe HJ
    Clin Res Cardiol; 2006; 95 Suppl 3():III22-8. PubMed ID: 16598600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remote monitoring of implantable-cardioverter defibrillators: results from the Reliability of IEGM Online Interpretation (RIONI) study.
    Perings C; Bauer WR; Bondke HJ; Mewis C; James M; Böcker D; Broadhurst P; Korte T; Toft E; Hintringer F; Clémenty J; Schwab JO
    Europace; 2011 Feb; 13(2):221-9. PubMed ID: 21252195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Home monitoring of implantable cardioverter-defibrillators: interpretation reliability of the second-generation "IEGM Online" system.
    Nägele H; Lipoldová J; Oswald H; Klein G; Elvan A; Vester E; Bauer W; Bondke H; Reif S; Daub C; Menzel F; Schrader J; Zach G
    Europace; 2015 Apr; 17(4):584-90. PubMed ID: 25567067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.
    Spencker S; Coban N; Koch L; Schirdewan A; Müller D
    Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trial design of the clinical evaluation of remote notification to reduce time to clinical decision: the Clinical evaluation Of remote NotificatioN to rEduCe Time to clinical decision (CONNECT) study.
    Crossley G; Boyle A; Vitense H; Sherfesee L; Mead RH
    Am Heart J; 2008 Nov; 156(5):840-6. PubMed ID: 19061696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inappropriate implantable cardioverter-defibrillator discharges unrelated to supraventricular tachyarrhythmias.
    Occhetta E; Bortnik M; Magnani A; Francalacci G; Marino P
    Europace; 2006 Oct; 8(10):863-9. PubMed ID: 16916859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and characteristics of appropriate and inappropriate therapies in recipients of ICD implanted for primary prevention of sudden cardiac death.
    Kreuz J; Balta O; Liliegren N; Mellert F; Esmailzadeh B; Nickenig G; Schwab JO
    Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S125-7. PubMed ID: 17302687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of sudden cardiac death: rationale and design of the Implantable Cardioverter Defibrillators in Dialysis patients (ICD2) Trial--a prospective pilot study.
    de Bie MK; Lekkerkerker JC; van Dam B; Gaasbeek A; van Buren M; Putter H; van Erven L; Bax JJ; Schalij MJ; Rabelink TJ; Jukema JW
    Curr Med Res Opin; 2008 Aug; 24(8):2151-7. PubMed ID: 18561878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automatic home monitoring of implantable cardioverter defibrillators.
    Nielsen JC; Kottkamp H; Zabel M; Aliot E; Kreutzer U; Bauer A; Schuchert A; Neuser H; Schumacher B; Schmidinger H; Stix G; Clémenty J; Danilovic D; Hindricks G
    Europace; 2008 Jun; 10(6):729-35. PubMed ID: 18434298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
    Marín F; Gimeno JR; Payá E; García-Alberola A; Pérez-Alvarez L; Fernández X; de la Morena G; Sogorb F; Castro-Beiras A; Valdés M; Martínez JG; Monserrat L
    Rev Esp Cardiol; 2006 Jun; 59(6):537-44. PubMed ID: 16790196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remote implantable cardioverter defibrillator monitoring in a Brugada syndrome population.
    Sacher F; Probst V; Bessouet M; Wright M; Maluski A; Abbey S; Bordachar P; Deplagne A; Ploux S; Lande G; Jaïs P; Hocini M; Haïssaguerre M; Le Marec H; Clémenty J
    Europace; 2009 Apr; 11(4):489-94. PubMed ID: 19218576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Rhythm ID Going Head to Head Trial (RIGHT): design of a randomized trial comparing competitive rhythm discrimination algorithms in implantable cardioverter defibrillators.
    Berger RD; Lerew DR; Smith JM; Pulling C; Gold MR
    J Cardiovasc Electrophysiol; 2006 Jul; 17(7):749-53. PubMed ID: 16836672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs and quality-of-life effects of implantable cardioverter-defibrillators.
    Groeneveld PW; Matta MA; Suh JJ; Heidenreich PA; Shea JA
    Am J Cardiol; 2006 Nov; 98(10):1409-15. PubMed ID: 17134641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
    Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F
    J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of atrial tachyarrhythmia detection in implantable devices with arrhythmia therapies.
    Purerfellner H; Gillis AM; Holbrook R; Hettrick DA
    Pacing Clin Electrophysiol; 2004 Jul; 27(7):983-92. PubMed ID: 15271020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardioverter defibrillators and quality of life: results from the defibrillators in nonischemic cardiomyopathy treatment evaluation study.
    Passman R; Subacius H; Ruo B; Schaechter A; Howard A; Sears SF; Kadish A
    Arch Intern Med; 2007 Nov; 167(20):2226-32. PubMed ID: 17998496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of remote monitoring in the reduction of inappropriate implantable cardioverter defibrillator therapies.
    Res JC; Theuns DA; Jordaens L
    Clin Res Cardiol; 2006; 95 Suppl 3():III17-21. PubMed ID: 16598599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microvolt T-wave alternans and the selective use of implantable cardioverter defibrillators for primary prevention: a cost-effectiveness study.
    Filion KB; Xie X; van der Avoort CJ; Dendukuri N; Brophy JM
    Int J Technol Assess Health Care; 2009 Apr; 25(2):151-60. PubMed ID: 19331707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: time to go beyond the initial shock.
    Mishkin JD; Saxonhouse SJ; Woo GW; Burkart TA; Miles WM; Conti JB; Schofield RS; Sears SF; Aranda JM
    J Am Coll Cardiol; 2009 Nov; 54(22):1993-2000. PubMed ID: 19926003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.